{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:31:01Z","timestamp":1791930661152,"version":"4.3.4"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T00:00:00Z","timestamp":1696204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Tumor-associated macrophages (TAMs) represent an important cell population within the tumor microenvironment, but little is known about the phenotype and function of these cells. The present study aims to characterize macrophages in high-grade serous ovarian cancer (HGSOC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Phenotype and expression of co-regulatory markers were assessed on TAMs derived from malignant ascites (MA) or peripheral blood (PB) by multiparametric flow cytometry. Samples were obtained from HGSOC patients (n=29) and healthy donors (HDs, n=16). Additional expression analysis was performed by RNAseq (n=192). Correlation with clinically relevant parameters was conducted and validated by a second patient cohort (n=517). Finally, the role of TIGIT in repolarization and phagocytosis was investigated\n                      <jats:italic>in vitro<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Expression of the M2-associated receptors CD163, CD204, and CD206, as well as of the co-regulatory receptors TIGIT, CD226, TIM-3, and LAG-3 was significantly more frequent on macrophages in HGSOC than in HDs. CD39 and CD73 were broadly expressed on (mainly M2) macrophages, but without a clear clustering in HGSOC. CD163 mRNA levels were higher in TAMs from patients with residual tumor mass after surgery and associated with a shorter overall survival. In addition, TIGIT expression was associated with a higher tumor grading, indicating a prognostic relevance of M2 infiltration in HGSOC. TIGIT blockade significantly reduced the frequency of M2 macrophages. Moreover, combined blockade of TIGIT and CD47 significantly increased phagocytosis of ovarian cancer cells by TAMs in comparison to a single blockade of CD47.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Combined blockade of TIGIT and CD47 represents a promising approach to enhance anti-CD47-facilitated phagocytosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2023.1250258","type":"journal-article","created":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T00:39:53Z","timestamp":1696293593000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Immunosuppressive M2 TAMs represent a promising target population to enhance phagocytosis of ovarian cancer cells in vitro"],"prefix":"10.3389","volume":"14","author":[{"given":"Franziska","family":"Brauneck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"Oliveira-Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Muschhammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabea","family":"Sturmheit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christin","family":"Ackermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedrich","family":"Haag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Schulze zur Wiesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minyue","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa","family":"Hell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Schmalfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Bokemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Fiedler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin","family":"Wellbrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,10,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20040952","article-title":"High-grade serous ovarian cancer: Basic sciences, clinical and therapeutic standpoints","volume":"20","author":"Lisio","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-0763-4","article-title":"Genetic heterogeneity and evolutionary history of high-grade ovarian carcinoma and matched distant metastases","volume":"122","author":"Masoodi","year":"2020","journal-title":"Br J Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3746","article-title":"Peritoneal tumor spread in serous ovarian cancer-epithelial mesenchymal status and outcome","volume":"6","author":"Auer","year":"2015","journal-title":"Oncotarget"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2022.940801","article-title":"Deciphering the immune landscape dominated by cancer-associated fibroblasts to investigate their potential in indicating prognosis and guiding therapeutic regimens in high grade serous ovarian carcinoma","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2021.799428","article-title":"Tumor-associated macrophages: critical players in drug resistance of breast cancer","volume":"12","author":"Xiao","year":"2021","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2021.642285","article-title":"Mechanisms of macrophage plasticity in the tumor environment: manipulating activation state to improve outcomes","volume":"12","author":"Ricketts","year":"2021","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/cells10092364","article-title":"Bringing macrophages to the frontline against cancer: Current immunotherapies targeting macrophages","volume":"10","author":"Reis-Sobreiro","year":"2021","journal-title":"Cells"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01731","article-title":"Redefining tumor-associated macrophage subpopulations and functions in the tumor microenvironment","volume":"11","author":"Wu","year":"2020","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-019-0760-3","article-title":"Tumor-associated macrophages in tumor metastasis: Biological roles and clinical therapeutic applications","volume":"12","author":"Lin","year":"2019","journal-title":"J Hematol Oncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-021-02089-2","article-title":"New insights into M1\/M2 macrophages: key modulators in cancer progression","volume":"21","author":"Liu","year":"2021","journal-title":"Cancer Cell Int"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/nri3073","article-title":"Protective and pathogenic functions of macrophage subsets","volume":"11","author":"Murray","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2018.01930","article-title":"Chemokine-induced macrophage polarization in inflammatory conditions","volume":"9","author":"Ruytinx","year":"2018","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-019-0568-z","article-title":"Tumor-associated macrophages: An accomplice in solid tumor progression","volume":"26","author":"Chen","year":"2019","journal-title":"J BioMed Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jitc-2020-001341","article-title":"Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer","volume":"9","author":"Li","year":"2021","journal-title":"J Immunother Cancer."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-020-02618-z","article-title":"Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients","volume":"18","author":"Hwang","year":"2020","journal-title":"J Transl Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2021.693517","article-title":"Tumor-associated macrophages: A potential target for cancer therapy","volume":"11","author":"Tan","year":"2021","journal-title":"Front Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.iotech.2022.100070","article-title":"CD47\u2013SIRP\u03b1-targeted therapeutics: status and prospects","volume":"13","author":"Maute","year":"2022","journal-title":"Immuno-Oncol. Technol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2021.768115","article-title":"Significance of CD47 and its association with tumor immune microenvironment heterogeneity in ovarian cancer","volume":"12","author":"Yu","year":"2021","journal-title":"Front Immunol"},{"key":"B19","article-title":"Overexpression of CD47 predicts poor prognosis and promotes cancer cell invasion in high-grade serous ovarian carcinoma","volume":"9","author":"Li","year":"2017","journal-title":"Am J Transl Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.02018","article-title":"First-in-human, first-in-class phase i trial of the anti-CD47 antibody Hu5F9-G4 in patients with advanced cancers","volume":"37","author":"Sikic","year":"2019","journal-title":"J Clin Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13246372","article-title":"Transcriptome analysis in vulvar squamous cell cancer","volume":"13","author":"Prieske","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: A flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/biostatistics\/4.2.249","article-title":"Exploration, normalization, and summaries of high density oligonucleotide array probe level data","volume":"4","author":"Irizarry","year":"2003","journal-title":"Biostatistics"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-004794","article-title":"TIGIT blockade repolarizes AML-associated TIGIT+ M2 macrophages to an M1 phenotype and increases CD47-mediated phagocytosis","volume":"10","author":"Brauneck","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2019.01512","article-title":"Evaluating the polarization of tumor-associated macrophages into M1 and M2 phenotypes in human cancer tissue: technicalities and challenges in routine clinical practice","volume":"9","author":"Jayasingam","year":"2020","journal-title":"Front Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","article-title":"Macrophages as tools and targets in cancer therapy","volume":"21","author":"Mantovani","year":"2022","journal-title":"Nat Rev Drug Discovery"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22136995","article-title":"Macrophage polarization states in the tumor microenvironment","volume":"22","author":"Boutilier","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-1693","article-title":"Intratumoral mediated immunosuppression is prognostic in genetically engineered murine models of glioma and correlates to immunotherapeutic responses","volume":"16","author":"Kong","year":"2010","journal-title":"Clin Cancer Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4906(02)02302-5","article-title":"Macrophage polarization: Tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2006.01.003","article-title":"Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy","volume":"42","author":"Sica","year":"2006","journal-title":"Eur J Cancer."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jitc-2020-000979","article-title":"M2-like macrophages dictate clinically relevant immunosuppression in metastatic ovarian cancer","volume":"8","author":"Hensler","year":"2020","journal-title":"J Immunother Cancer."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms17030320","article-title":"CD86+\/CD206+, diametrically polarized tumor-associated macrophages, predict hepatocellular carcinoma patient prognosis","volume":"17","author":"Dong","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.immuni.2016.05.001","article-title":"Lag-3, tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation","volume":"44","author":"Anderson","year":"2016","journal-title":"Immunity"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/nature22396","article-title":"PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity","volume":"545","author":"Gordon","year":"2017","journal-title":"Nature"},{"key":"B36","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.imbio.2015.08.003","article-title":"TIGIT negatively regulates inflammation by altering macrophage phenotype","volume":"221","author":"Chen","year":"2016","journal-title":"Immunobiology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/2162402X.2016.1211219","article-title":"Tim-3 promotes tumor-promoting M2 macrophage polarization by binding to STAT1 and suppressing the STAT1-miR-155 signaling axis","volume":"5","author":"Jiang","year":"2016","journal-title":"Oncoimmunology"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1080\/14737140.2021.1865814","article-title":"TIM-3 pathway dysregulation and targeting in cancer","volume":"21","author":"Zeidan","year":"2021","journal-title":"Expert Rev Anticancer Ther"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045466","article-title":"High-resolution transcriptome of human macrophages","volume":"7","author":"Beyer","year":"2012","journal-title":"PloS One"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1080\/08820139.2022.2065921","article-title":"The effect of CD226 on the balance between inflammatory monocytes and small peritoneal macrophages in mouse ulcerative colitis","volume":"51","author":"Li","year":"2022","journal-title":"Immunol Invest"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20151899","article-title":"Inflammatory monocytes and NK cells play a crucial role in DNAM-1-dependent control of cytomegalovirus infection","volume":"213","author":"Rovis","year":"2016","journal-title":"J Exp Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0413236","article-title":"Extrinsic and intrinsic control of macrophage inflammatory responses","volume":"94","author":"Cohen","year":"2013","journal-title":"J Leukoc Biol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0376-4","volume":"20","author":"Moesta","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jitc-2019-000186","article-title":"On the mechanism of anti-CD39 immune checkpoint therapy","volume":"8","author":"Allard","year":"2020","journal-title":"J Immunother Cancer."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2020.566511","article-title":"Tumor-associated macrophages in human breast, colorectal, lung, ovarian and prostate cancers","volume":"10","author":"Larionova","year":"2020","journal-title":"Front Oncol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.7785\/tcrt.2012.500312","article-title":"Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer","volume":"12","author":"Lan","year":"2013","journal-title":"Technol Cancer Res Treat"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2017.07.007","article-title":"Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis","volume":"147","author":"Yuan","year":"2017","journal-title":"Gynecol Oncol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0601-2","article-title":"CD47-ligation induced cell death in T-acute lymphoblastic leukemia article","volume":"9","author":"Leclair","year":"2018","journal-title":"Cell Death Dis"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2022.899068","article-title":"CD47-SIRP\u03b1 Controls ADCC killing of primary T cells by PMN through a combination of trogocytosis and NADPH oxidase activation","volume":"13","author":"Gondois-Rey","year":"2022","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1250258\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T09:42:00Z","timestamp":1696844520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1250258\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,2]]},"references-count":49,"alternative-id":["10.3389\/fimmu.2023.1250258"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1250258","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,2]]},"article-number":"1250258"}}